FastTrac® TechVenture™ - For technology and life science entrepreneurs
Course - United States
Why has the current success rate for life sciences startups stayed at three out of 10?
Achieving success in the life sciences arena requires vision, a well-defined business plan, great execution, and lots of capital,(or a well executed license and acquisition strategy). Clinical trials and the wait for FDA approval can greatly extend the non-revenue period. Having a flawless plan strengthens a life science company’s credibility and helps meet that next milestone on the road to profitability or a key value inflection point.
Mechanism of Action is just the beginning of what it takes to be successful. The majority of functions that must be performed perfectly include:
Patient population economics
Regulatory strategies; right protocol, achievable/smart endpoints, correct patient participants
Determining a 505(b)(2) or 505(b)(1) development program pathway
Determining a 510(K) or PMA development program pathway
Reimbursement strategies; differing reimbursement environments, multiple codes, limited reimbursement & attended monitoring
Strategic pricing criteria
(Courtesy of http://properohca.affiliate.fasttrac.org/)
Mon, Nov 26, 2012 — Feb 11, 2013
FastTrac® TechVenture™ for LifeSciences™
Loeb & Loeb, 345 Park Ave, 21st Fl Conference Center, New York, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
